(a) nonsignificant expression between ovarian cancer and normal ovarian tissues (eg, PD-1 and PD-L1); (b) upregulated or downregulated in ovarian cancer but no significant difference existed in the OS and DFS of ovarian cancer patients (eg, TIM-3 and LAG3). Here, HAVCR2 is linked to ovarian cancer.